Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression

Despite the increasing incidence of endometrial cancer (EC) worldwide and the poor overall survival of patients who recur, no reliable biomarker exists for detecting and monitoring EC recurrence and progression during routine follow-up. Circulating tumor DNA (ctDNA) is a sensitive method for monitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Moss, Esther L., Gorsia, Diviya N., Collins, Anna, Sandhu, Pavandeep, Foreman, Nalini, Gore, Anupama, Wood, Joey, Kent, Christopher, Silcock, Lee, Guttery, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463944/
https://www.ncbi.nlm.nih.gov/pubmed/32785174
http://dx.doi.org/10.3390/cancers12082231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463944/
https://www.ncbi.nlm.nih.gov/pubmed/32785174
http://dx.doi.org/10.3390/cancers12082231

Ejemplares similares